MINNEAPOLIS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with ...
MINNEAPOLIS, July 25, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment ...
Tactile Systems Technology has raised its revenue guidance for FY 2018. Flexitouch is the primary growth driver for Tactile Systems technology. Line extensions are strengthening Tactile Systems ...
MINNEAPOLIS, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the ...
About Tactile Systems Technology Inc. Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases. It provides lymphedema ...
Tactile Systems Technology’s consensus analyst price target remains steady at $16.83 per share, reflecting unchanged expectations for the company’s future valuation. This stability comes as analysts ...
MINNEAPOLIS, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the ...
About Tactile Systems Technology Inc. Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases. It provides lymphedema ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback